Cargando…
Development of Zika Virus Vaccines
Zika virus (ZIKV) is a mosquito-borne flavivirus that emerged as a global threat following the most recent outbreak in Brazil in 2015. ZIKV infection of pregnant women is associated with fetal abnormalities such as microcephaly, and infection of adults can lead to Guillain–Barré syndrome, an autoimm...
Autores principales: | Makhluf, Huda, Shresta, Sujan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874648/ https://www.ncbi.nlm.nih.gov/pubmed/29346287 http://dx.doi.org/10.3390/vaccines6010007 |
Ejemplares similares
-
Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development
por: Elong Ngono, Annie, et al.
Publicado: (2019) -
Tracking the Evolution of Dengue Virus Strains D2S10 and D2S20 by 454 Pyrosequencing
por: Makhluf, Huda, et al.
Publicado: (2013) -
Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand
por: Hattakam, Sararat, et al.
Publicado: (2021) -
CD4(+) T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection
por: Wen, Jinsheng, et al.
Publicado: (2020) -
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)